IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,065 | +2.2% | 45,522 | -7.6% | 0.10% | +10.2% |
| Q2 2023 | $2,021 | -3.6% | 49,252 | -16.0% | 0.09% | -11.1% |
| Q1 2023 | $2,096 | -24.6% | 58,652 | -20.3% | 0.10% | -35.7% |
| Q4 2022 | $2,778 | -99.9% | 73,547 | +20.7% | 0.15% | -5.5% |
| Q3 2022 | $2,695,000 | +192.3% | 60,937 | +144.7% | 0.16% | +136.2% |
| Q2 2022 | $922,000 | +86.6% | 24,900 | +86.6% | 0.07% | +115.6% |
| Q1 2022 | $494,000 | -57.7% | 13,344 | -65.3% | 0.03% | -78.1% |
| Q4 2021 | $1,169,000 | +48.5% | 38,430 | +63.7% | 0.15% | +39.0% |
| Q3 2021 | $787,000 | – | 23,474 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |